Notice of a Meeting of a Working Group of the NIH Blue Ribbon Panel, 16223 [E9-8009]

Download as PDF Federal Register / Vol. 74, No. 67 / Thursday, April 9, 2009 / Notices Bethesda, MD 20894. 301–496–6921. Sheldon Kotzin@nlm.nih.gov. Any interested person may file written comments with the Committee by forwarding the statement to the Contact Person listed on this Notice. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance into the building by nongovernment employees. Persons without a government I.D. will need to show a photo ID. and sign in at the security desk upon entering the building. (Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, I– IHS) Dated: March 31, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy, NIH. [FR Doc. E9–7731 Filed 4–8–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health dwashington3 on PROD1PC60 with NOTICES Notice of a Meeting of a Working Group of the NIH Blue Ribbon Panel The purpose of this notice is to inform the public about a meeting of the NIH Blue Ribbon Panel to Advise on the Risk Assessment of the National Emerging Infectious Diseases Laboratories at Boston University Medical Center. The meeting will be held Tuesday, May 5, 2009 at the National Institutes of Health, Building 31, 31 Center Drive, Floor 6C, Room 6, Bethesda, MD 20892 from approximately 9 a.m. to 12 p.m. The purpose of the meeting is for the Panel to review and discuss progress on the supplementary risk assessment being conducted for the Boston University NEIDL. The National Research Council Committee on Technical Input will participate in this discussion and provide its views. Public comment will begin at approximately 11:30 a.m. In the event that time does not allow for all those interested to present oral comments, anyone may file written comments by sending them to the address below. Comments should include the name, address, telephone number and when applicable, the business or professional affiliation of the commenter. The meeting will be open to the public, with attendance limited to space available. There will be a live Web cast of the meeting which can be accessed at https://nihblueribbonpanel-bumcneidl.od.nih.gov/. Individuals who plan VerDate Nov<24>2008 15:28 Apr 08, 2009 Jkt 217001 to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. A draft agenda and slides for the meeting may be obtained by connecting to https://nihblueribbonpanel-bumcneidl.od.nih.gov/. For additional information concerning this meeting, contact Ms. Laurie Lewallen, Advisory Committee Coordinator, Office of Biotechnology Activities, Office of Science Policy, Office of the Director, National Institutes of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892–7985; telephone 301–496– 9838; e-mail lewallenl@od.nih.gov. Dated: April 2, 2009. Amy P. Patterson, Acting Director, Office of Science Policy, National Institutes of Health. [FR Doc. E9–8009 Filed 4–8–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Fiscal Year (FY) 2009 Funding Opportunity AGENCY: Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice of intent to award a Single Source Grant to Case Management, Inc. (CMI), Memphis, TN. SUMMARY: This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) intends to award approximately $500,000 (total costs) per year for up to two years to Case Management, Inc. (CMI), Memphis, TN. This is not a formal request for applications. Assistance will be provided only to Case Management, Inc. (CMI) based on the receipt of a satisfactory application that is approved by an independent review group. Funding Opportunity Title: Services Grant Program for Residential Treatment PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 16223 for Pregnant and Postpartum Women— Babylove II; TI–09–009. Catalog of Federal Domestic Assistance (CFDA) Number: 93.243. Authority: Section 508 of the Public Health Service Act, as amended. Justification: Only Case Management, Inc. (CMI) is eligible to apply. The Substance Abuse and Mental Health Services Administration (SAMHSA) is seeking to award a single source grant to Case Management, Inc. (CMI) to carry out the remainder of the CSAT-funded FY 2008 PPW Babylove II Project. Midtown Mental Health Center (MMHC), the recipient of an FY 2008 CSAT PPW grant award, notified SAMHSA that it: had ceased business; had been recently acquired by Case Management, Inc. (CMI); and transferred its contacts and patients to CMI effective September 16, 2008. Furthermore, CMI had assumed all of MMHC’s existing obligations under patient care contracts and/or grants. This transfer included relinquishing the FY 2008 CSAT PPW grant award issued on September 1, 2008, and transferring all associated patient services provided by the SAMHSA/CSAT grant-funded Babylove II Program. The Babylove II PPW Project is currently the only program in West Tennessee that provides specialized long-term residential treatment services for pregnant and postpartum women with co-occurring disorders, where the children can reside in the residential treatment facility with their mothers. CMI has been approved by SAMHSA/ CSAT Grants Management as the replacement grantee for the remainder of the current budget period (12/16/08– 9/29/09). According to the Awarding Agency Grants Administration Manual (AAGAM), as a replacement grantee, CMI is not automatically approved for the future budget years (i.e., years 2 and 3). This sole source grant will cover the future budget years of this 3 year grant program. Contact: Shelly Hara, Substance Abuse and Mental Health Services Administration, 1 Choke Cherry Road, Room 8–1081, Rockville, MD 20857; telephone: (240) 276–2321; e-mail: shelly.hara@samhsa.hhs.gov. Toian Vaughn, SAMHSA Committee Management Officer. [FR Doc. E9–8053 Filed 4–8–09; 8:45 am] BILLING CODE 4162–20–P E:\FR\FM\09APN1.SGM 09APN1

Agencies

[Federal Register Volume 74, Number 67 (Thursday, April 9, 2009)]
[Notices]
[Page 16223]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-8009]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of a Meeting of a Working Group of the NIH Blue Ribbon 
Panel

    The purpose of this notice is to inform the public about a meeting 
of the NIH Blue Ribbon Panel to Advise on the Risk Assessment of the 
National Emerging Infectious Diseases Laboratories at Boston University 
Medical Center.
    The meeting will be held Tuesday, May 5, 2009 at the National 
Institutes of Health, Building 31, 31 Center Drive, Floor 6C, Room 6, 
Bethesda, MD 20892 from approximately 9 a.m. to 12 p.m. The purpose of 
the meeting is for the Panel to review and discuss progress on the 
supplementary risk assessment being conducted for the Boston University 
NEIDL. The National Research Council Committee on Technical Input will 
participate in this discussion and provide its views.
    Public comment will begin at approximately 11:30 a.m. In the event 
that time does not allow for all those interested to present oral 
comments, anyone may file written comments by sending them to the 
address below. Comments should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the commenter.
    The meeting will be open to the public, with attendance limited to 
space available. There will be a live Web cast of the meeting which can 
be accessed at https://nihblueribbonpanel-bumc-neidl.od.nih.gov/. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one form 
of identification (for example, a government-issued photo ID, driver's 
license, or passport) and to state the purpose of their visit.
    A draft agenda and slides for the meeting may be obtained by 
connecting to https://nihblueribbonpanel-bumc-neidl.od.nih.gov/. For 
additional information concerning this meeting, contact Ms. Laurie 
Lewallen, Advisory Committee Coordinator, Office of Biotechnology 
Activities, Office of Science Policy, Office of the Director, National 
Institutes of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 
20892-7985; telephone 301-496-9838; e-mail lewallenl@od.nih.gov.

    Dated: April 2, 2009.
Amy P. Patterson,
Acting Director, Office of Science Policy, National Institutes of 
Health.

 [FR Doc. E9-8009 Filed 4-8-09; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.